1228029-77-3

Basic information

• Product Name: racemic-(3aS*,4S*,6aR*)-2-benzyloctahydrocyclopenta[c]pyrrol-4-ol
• Synonyms: racemic-(3aS*,4S*,6aR*)-2-benzyloctahydrocyclopenta[c]pyrrol-4-ol
• CAS NO: 1228029-77-3
• Molecular Weight: 217.311
• Mol File: 1228029-77-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: racemic-(3aS*,4S*,6aR*)-2-benzyloctahydrocyclopenta[c]pyrrol-4-ol(CAS DataBase Reference)
• NIST Chemistry Reference: racemic-(3aS*,4S*,6aR*)-2-benzyloctahydrocyclopenta[c]pyrrol-4-ol(1228029-77-3)
• EPA Substance Registry System: racemic-(3aS*,4S*,6aR*)-2-benzyloctahydrocyclopenta[c]pyrrol-4-ol(1228029-77-3)

Safety Data

• Hazardous Substances Data: 1228029-77-3(Hazardous Substances Data)

Upstream product

• 185692-51-7 7-Benzyl-2-oxo-7-azabicyclo[3.3.0]octane 
• 174293-33-5 (3aS,6aR)-2-benzylhexahydrocyclopenta[c]pyrrol-4(5H)-one 

Downstream Products

• 1228029-78-4 (3aS,4S,6aR)-2-Benzyloctahydrocyclopenta[c]pyrrol-4-yl methanesulfonate 
• 1228028-97-4 N₂,N₂-dimethyl-N₁-((3aS,4R,6aR)-2-{[3-(trifluoromethyl)phenyl]sulfonyl}octahydrocyclopenta[c]pyrrol-4-yl)-L-leucinamide 
• 1228025-68-0 N₂-methyl-N₁-((3aS,4R,6aR)-2-{[4-(trifluoromethyl)phenyl]sulfonyl}octahydrocyclopenta[c]pyrrol-4-yl)-L-leucinamide 
• 1228025-67-9 N₂-methyl-N₁-((3aS,4R,6aR)-2-{[3-(trifluoromethyl)phenyl]sulfonyl}octahydrocyclopenta[c]pyrrol-4-yl)-L-leucinamide 
• 1228025-69-1 N₁-((3aS,4R,6aR)-2-{[3-(trifluoromethyl)phenyl]sulfonyl}octahydrocyclopenta[c]pyrrol-4-yl)-L-leucinamide 
• 1228027-09-5 tert-butyl methyl((S)-4-methyl-1-oxo-1-((3aS,4R,6aR)-2-(4-(trifluoromethyl)phenylsulfonyl)octahydrocyclopenta[c]pyrrol-4-ylamino)pentan-2-yl)carbamate 
• 1228027-10-8 tert-butyl methyl((S)-4-methyl-1-oxo-1-((3aS,4R,6aR)-2-(3-(trifluoromethyl)phenylsulfonyl)octahydrocyclopenta[c]pyrrol-4-ylamino)pentan-2-yl)carbamate 
• 1449789-74-5 C₂₅H₃₆F₃N₃O₅S 
• 1228025-42-0 N₁-[(3aS,4R,6aR)-2-benzyloctahydrocyclopenta[c]pyrrol-4-yl]-N₂-(tert-butyloxycarbonyl)-N₂-methyl-L-leucinamide 
• 1228029-98-8 N₁-[(3aS,4R,6aR)-2-benzyloctahydrocyclopenta[c]pyrrol-4-yl]-N₂-(tert-butyloxycarbonyl)-L-leucinamide 
• 1228029-80-8 (3aS,4R,6aR)-2-benzyloctahydrocyclopenta[c]pyrrol-4-amine 
• 1228029-79-5 (3aS,4R,6aR)-4-azido-2-benzyloctahydrocyclopenta[c]pyrrole 
• 130658-13-8 racemic-tert-butyl (3aS*,4S*,6aR*)-4-hydroxyhexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate 

Relevant articles and documents

Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic pain

A novel series of N-type calcium channel inhibitors have been discovered. Optimization of potency and HT-ADME properties provides 4- aminocyclopentapyrrolidines with analgesic efficacy after oral dosing.

N-ALKYL-AZACYCLOALKYL NMDA/NR2B ANTAGONISTS

Compounds represented by Formula (I): and/or pharmaceutically acceptable salts, individual enantiomers and stereoisomers thereof, are effective as NMDA/NR2B antagonists useful for treating conditions such as pain, Parkinson’s disease, Alzheimer’s disease, epilepsy, depression, anxiety, ischemic brain injury including stroke.